Results 161 to 170 of about 2,731,986 (326)

Rebalancing Hemostasis: Fitusiran as a First‐in‐Class RNAi Therapy in Hemophilia A and B

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Fitusiran is a first‐in‐class RNA interference (RNAi) therapy that lowers antithrombin (AT) to rebalance hemostasis in people with Hemophilia A or B, with or without inhibitors. Its recent FDA approval marks a major shift toward factor‐independent prophylaxis.
Raza Ur Rehman, Rida Fatima, Aymar Akilimali   +2 more
wiley   +1 more source

Biliary infections: cholecystitis [PDF]

, 2009
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of ...
Kaapuraala, Abhishake
core  

Treatment Strategies for Acute Cholecystitis of Patients with Sub- and Decompensated Cardiovascular Diseases [PDF]

, 2016
N. Yu. Kokhanenko, Andrey Lvovich Lugovoy, Sergey A. Danilov, А И Иванов, Lekso Zurabovich Gurtskaya   +4 more
openalex   +1 more source

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis

Journal of hepato-biliary-pancreatic sciences, 2018
Kohji Okamoto, Kenji Suzuki, T. Takada, S. Strasberg, H. Asbun, I. Endo, Y. Iwashita, T. Hibi, H. Pitt, A. Umezawa, K. Asai, Ho-Seong Han, T. Hwang, Yasuhisa Mori, Yoo-Seok Yoon, Wayne Shih‐Wei Huang, G. Belli, C. Dervenis, M. Yokoe, S. Kiriyama, T. Itoi, P. Jagannath, O. Garden, F. Miura, Masafumi Nakamura, A. Horiguchi, G. Wakabayashi, D. Cherqui, E. Santibanes, S. Shikata, Y. Noguchi, Tomohiko Ukai, R. Higuchi, K. Wada, G. Honda, A. Supe, Masahiro Yoshida, T. Mayumi, D. Gouma, D. Deziel, K. Liau, Miin‐Fu Chen, K. Shibao, Keng-Hao Liu, C. Su, A. Chan, D. Yoon, I. Choi, E. Jonas, Xiao-ping Chen, S. Fan, C. Ker, M. Giménez, S. Kitano, M. Inomata, K. Hirata, K. Inui, Y. Sumiyama, Masakazu Yamamoto   +58 more
semanticscholar   +1 more source

Acute cholecystitis

BMJ, 2002
Adrian A, Indar, Ian J, Beckingham
openaire   +3 more sources

Differentiation of Gallbladder Adenomyomatosis and Polyps in a Western Cohort: Prevalence, Ultrasound Characteristics, and Diagnostic Challenges

JGH Open, Volume 10, Issue 1, January 2026.
ABSTRACT Background Gallbladder adenomyomatosis and polyps are common benign lesions that can mimic malignancy on imaging, often leading to unnecessary cholecystectomy. Despite frequent sonographic detection, the prevalence of adenomyomatosis in living cohorts remains poorly defined.
Marie Neumann, Michael Kallenbach, Ulrike Morgera, Andrea Cariati, Lars Morawietz, Frank Jacobsen, Frank Dubois, Sebastian Herberger, Falko Hanisch, Slim Khouja, Wolfram Wermke, Yvonne Dörffel   +11 more
wiley   +1 more source

Salmonella Cholecystitis: Atypical Presentation of a Typical Condition [PDF]

, 2013
Salmonella cholecystitis is a rare but important complication of Salmonella typhi infection. We are reporting an 11 years old female child who presented with complaints of high-grade fever, jaundice and right sided abdominal pain (Charcot\u27s triad ...
Ahmed, Shakeel, Ali, Rehan, Atiq, Huba, Hamid, Muhammad, Qadir, Maqbool   +4 more
core   +1 more source

Left Approach for Difficult Laparoscopic Cholecystectomy in Acute Cholecystitis [PDF]

, 2017
Hatem Elgohary, Mohamed A. Nada
openalex   +1 more source

A Case of Canine Gallbladder Mucocele With Intramural Haematoma and Rupture

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
A 10‐year‐old, neutered male, Poodle mix presented for evaluation of anorexia, vomiting and elevated liver enzymes. The patient underwent emergent cholecystectomy for suspicion of a ruptured gallbladder mucocele with a possible concurrent mass effect within the gallbladder.
Kira H. Lin, Whitney Zoll, Morgan Biggo
wiley   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

Journal of the American Geriatrics Society, Volume 74, Issue 1, Page 96-106, January 2026.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen, Yu‐Wei Fang, Ya‐Fang Liu, Mon‐Ting Chen, Ming‐Hsien Tsai   +4 more
wiley   +1 more source